Cell Therapy
首页 >投资领域>Treatment technique of immune cells

Immune cells

  Immune cells (Cell Immune) is commonly known as white blood cells, including lymphocytes and a variety of phagocytic cells, but also in particular can recognize antigens, produce specific immune response of lymphocytes and so on. Lymphocyte is the basic component of the immune system, which is widely distributed in the body, mainly T lymphocytes, B lymphocytes are activated by antigen stimulation, the proliferation of cell division, the occurrence of specific immune response. In addition to T lymphocytes and B lymphocytes, there are K lymphocytes and NK lymphocytes, a total of four types. In addition to lymphocytes, cells that are involved in the immune response are plasma cells, granulocyte, mast cells, antigen presenting cells, and cells of the mononuclear phagocytic system.

Cellular immune therapy

  The treatment of immune cells, it is aimed at how to prevent the recurrence of malignant tumors and its main principle is to peripheral blood mononuclear cells in patients with (a belongs to immune cells) isolated in vitro by specific antigen and cultured in the laboratory, the ability to prepare a specific tumor killing at the same time, the in vitro cell expansion to increase after a certain number of re injected into the body, killing those invisible tumor cells, thereby preventing tumor recurrence and metastasis, to a certain extent, poor immunity of patients after radiotherapy and chemotherapy to solve the serious problem of low quality of life, and the mechanism of autologous cell immunotherapy can improve the immunity of the patients, so to a certain extent can greatly extend the survival time of patients with ling. The ark program, which began in the early twenty-first Century, has made a great progress in the treatment of cancer.

Cellular immunotherapy has no obvious side effects, and occasionally makes patients have mild fever in the course of the return.